Fosinopril decreases levels of soluble vascular cell adhesion in molecule-1 borderline hypertensive type II diabetic patients with microalbuminuria

American Journal of Hypertension

Volumn 12, Issue 2 I, 1999, Pages 217-222

  Gasic, S ^a   Wagner, O F ^a   Fasching, P ^a   Ludwig, C ^a   Veitl, M ^a   Kapiotis, S ^a   Jilma, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiotensin converting enzyme inhibitor; Diabetic microalbuminuria; E selectin; Fosinopril; Vascular cell adhesion molecule 1

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FOSINOPRIL; GLUCOSE; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BORDERLINE HYPERTENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FIBRINOLYSIS; HUMAN; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0033034629     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00229-5     Document Type: Article

References (48)

1. M.H Alderman S Madhavan W.L Ooi Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension N Engl J Med 324 1991 1098 1104
2. R.J Cody The integrated effects of angiotensin II Am J Cardiol 79 1997 9 11
3. M.E Cooper Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients J Hypertens 14 suppl 1996 S11 S14
4. H Drexler S Kurz M Jeserich Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure Am J Cardiol 76 1995 13E 18E
5. K.M Wood M.D Cadogan A.L Ramshaw The distribution of adhesion molecules in human atherosclerosis Histopathology 22 1993 437 444
6. A.C Van der Wal P.K Das A.J Tigges Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions Am J Pathol 141 1992 1427 1433
7. R Pigott L.P Dillon I.H Hemingway Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells Biochem Biophys Res Commun 187 1992 584 589
8. M.W Boehme R Waldherr A Kist Kinetics of soluble TNF-receptors and soluble adhesion molecules ICAM-1, E-selectin and VCAM-1 under systemic rhTNF alpha therapy Eur J Clin Invest 26 1996 404 410
9. Gearing AJ, Hemingway I, Pigott R, et al: Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 1992;667–1995.
10. A.D Blann J Amiral C.N McCollum Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease Br J Haematol 95 1996 263 265
11. A.D Blann C.N McCollum Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis Thromb Haemost 72 1994 151 154
12. M Steiner K.M Reinhardt B Krammer Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control Thromb Haemost 72 1994 979 984
13. O.F Wagner B Jilma Putative role of adhesion molecules in metabolic disorders Horm Metab Res 29 1997 1 4
14. P Fasching M Veitl M Rohac Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus J Clin Endocrinol Metab 81 1996 4313 4317
15. A.M Schmidt J Crandall O Hori Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria a marker of vascular dysfunction and progressive vascular disease Br J Haematol 92 1996 747 750
16. D.E Vaughan The renin-angiotensin system and fibrinolysis Am J Cardiol 79 1997 12 16
17. A Hamsten U de Faire G Walldius Plasminogen activator inhibitor in plasma risk factor for recurrent myocardial infarction Lancet ii 1987 3 9
18. J.B McGill D.L Schneider C.L Arfken Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients Diabetes 43 1994 104 109
19. R Jokl R.L Klein M.F Lopes-Virella Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes Diabet Care 8 1995 1150 1155
20. Nagi DK, Mohamad Ali V, Jain SK, et al: Plaminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non–insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Diabet Med 1996;59–64.
21. A.B Bridges M McLaren J.J Belch A comparative study of captopril and enalapril on endothelial cell function in congestive heart failure patients Angiology 46 1995 811 817
22. D.E Vaughan J.L Rouleau P.M Ridker Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators Circulation 96 1997 442 447
23. A.D Blann W Tse S.J Maxwell Increased levels of the soluble adhesion molecule E-selectin in essential hypertension J Hypertens 12 1994 925 928
24. L Cominacini A Fratta Pasini U Garbin E-Selectin plasma concentration is influenced by glycaemic control in NIDDM patients possible role of oxidative stress Diabetologia 40 1997 584 589
25. B Jilma H.G Eichler H Breiteneder Effects of 17 beta-estradiol on circulating adhesion molecules J Clin Endocrinol Metab 79 1994 1619 1624
26. B Jilma T Szalay E Dirnberger Effect of endothelin-1 on circulating adhesion molecules in man Eur J Clin Invest 27 1997 850 856
27. P.D Stolley B.L Strom Sample size calculations for clinical pharmacology studies Clin Pharmacol Ther 39 1986 489 490
28. D.A Sica T.W.B Gehr K.L Duchin The pharmacology and pharmacokinetics of fosinopril Rev Contemp Pharmacother 4 1993 1 15
29. S Kapiotis B Jilma T Szalay Evidence against an effect of endothelin-1 on blood coagulation, fibrinolysis, and endothelial cell integrity in healthy men Arterioscler Thromb Vasc Biol 17 1997 2861 2867
30. S Kapiotis B Jilma S Handler Morning hypercoagulability and hypofibrinolysis diurnal variations in circulating activated factor FVII and plasmin-plasmin inhibitor complex Circulation 96 1997 19 21
31. P Fasching W Waldhausl O.F Wagner Elevated circulating adhesion molecules in NIDDM—potential mediators in diabetic macroangiopathy (letter) Diabetologia 39 1996 1242 1244
32. B Jilma P Fasching C Ruthner Elevated circulating P-selectin in insulin dependent diabetes mellitus Thromb Haemost 76 1996 328 332
33. B.V Khan D.G Harrison M.T Olbrych Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells Proc Natl Acad Sci USA 93 1996 9114 9119
34. P.S Tsao R Buitrago J.R Chan Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1 Circulation 94 1996 1682 1689
35. M Takahashi U Ikeda J Masuyama Nitric oxide attenuates adhesion molecule expression in human endothelial cells Cytokine 8 1996 817 821
36. K Krejcy H.G Eichler B Jilma Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo Can J Physiol Pharmacol 74 1996 9 14
37. A.M Schmidt O Hori J.X Chen Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes J Clin Invest 96 1995 1395 1403
38. A Kautzky Willer P Fasching B Jilma Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus J Clin Endocrinol Metab 82 1997 4117 4121
39. K Peter P Nawroth C Conradt Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin Arterioscler Thromb Vasc Biol 17 1997 505 512
40. J.A Olson C.M Whitelaw K.C McHardy Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration Diabetologia 40 1997 1166 1171
41. H Rabb R Rosen G Ramirez VLA-4 and its ligands relevance to kidney diseases Springer Semin Immunopathol 16 1995 417 425
42. A.E Koch M.M Halloran C.J Haskell Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 Nature 376 1995 517 519
43. L Cominacini A Fratta Pasini U Garbin Elevated levels of soluble E-selectin in patients with IDDM and NIDDM relation to metabolic control Diabetologia 38 1995 1122 1124
44. M Zehetgruber R Beckmann H Gabriel The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters Thromb Res 83 1996 143 152
45. R.A Wright A.D Flapan K.G Alberti Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction J Am Coll Cardiol 24 1994 67 73
46. N.A Booth J.A Anderson B Bennett Platelet release protein which inhibits plasminogen activators J Clin Pathol 38 1985 825 830
47. C.D Stehouwer J Lambert A.J Donker Endothelial dysfunction and pathogenesis of diabetic angiopathy Cardiovasc Res 34 1997 55 68
48. T Wascher Endothelial transport processes and tissue metabolism evidence for microvascular endothelial dysfunction in insulin-resistant diseases? Eur J Clin Invest 27 1997 831 835